John G Ullman & Associates Inc Horizon Therapeutics Public LTD CO Transaction History

John G Ullman & Associates Inc

$649 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	SELL	$98.98 - $115.74 $94,031 - $109,953	-950 Reduced 1.19%	78,762 $9.11 Million
Q2 2023 Aug 21, 2023	SELL	$96.34 - $112.38 $219,173 - $255,664	-2,275 Reduced 2.77%	79,712 $8.2 Million
Q1 2023 May 05, 2023	SELL	$107.32 - $113.5 $147,565 - $156,062	-1,375 Reduced 1.65%	81,987 $8.95 Million
Q4 2022 Feb 08, 2023	SELL	$62.39 - $113.8 $289,489 - $528,032	-4,640 Reduced 5.27%	83,362 $9.49 Million
Q3 2022 Oct 19, 2022	BUY	$58.92 - $84.67 $147,300 - $211,675	2,500 Added 2.92%	88,002 $5.45 Million
Q2 2022 Jul 27, 2022	BUY	$79.4 - $116.36 $1.48 Million - $2.16 Million	18,600 Added 27.8%	85,502 $6.82 Million
Q1 2022 Apr 29, 2022	SELL	$86.42 - $109.81 $140,432 - $178,441	-1,625 Reduced 2.37%	66,902 $7.04 Million
Q4 2021 Jan 26, 2022	SELL	$98.56 - $119.91 $83,776 - $101,923	-850 Reduced 1.23%	68,527 $7.38 Million
Q3 2021 Nov 02, 2021	SELL	$91.91 - $110.37 $70,494 - $84,653	-767 Reduced 1.09%	69,377 $7.6 Million
Q2 2021 Jul 23, 2021	SELL	$86.24 - $95.92 $188,261 - $209,393	-2,183 Reduced 3.02%	70,144 $6.57 Million
Q1 2021 Apr 22, 2021	SELL	$71.83 - $95.48 $229,856 - $305,536	-3,200 Reduced 4.24%	72,327 $6.66 Million
Q4 2020 Feb 05, 2021	SELL	$67.0 - $84.39 $61,975 - $78,060	-925 Reduced 1.21%	75,527 $5.53 Million
Q3 2020 Nov 06, 2020	SELL	$55.23 - $79.93 $22,092 - $31,972	-400 Reduced 0.52%	76,452 $5.94 Million
Q2 2020 Jul 29, 2020	SELL	$30.2 - $56.98 $6,040 - $11,396	-200 Reduced 0.26%	76,852 $4.27 Million
Q1 2020 Apr 14, 2020	SELL	$24.87 - $38.56 $32,331 - $50,128	-1,300 Reduced 1.66%	77,052 $2.28 Million
Q4 2019 Jan 29, 2020	SELL	$25.43 - $36.67 $30,516 - $44,004	-1,200 Reduced 1.51%	78,352 $2.84 Million
Q3 2019 Oct 21, 2019	BUY	$23.0 - $27.97 $1.83 Million - $2.23 Million	79,552 New	79,552 $2.17 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of John G Ullman & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on John G Ullman & Associates Inc with notifications on news.

Account